大行評級|花旗:上調中國民航信息網絡目標價至12.6港元 評級升至“買入”
花旗發表報吿指,中國民航信息網絡預期去年淨利潤逾20.5億元,相當於按年增長不少於41.4%,較該行和市場預期分別高出11%和7%,意味着去年下半年合併淨利潤至少有6.73億,意味按年增長180%以上。花旗指,中航信年初至今股價僅持平,落後於內地同業,可能是對於下半年業績的憂慮。該行預期公司2025至2026年盈利將逐步改善,帶動股價從下行週期中獲估值重評;同時上調對其2024至2026年每股盈利預測各13%、8%及5%,以反映去年度盈喜,以及2025和年2026年效率提升帶來的經營槓桿改善。該行對其目標價由10.2港元升至12.6港元,評級由“中性”升至“買入”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.